PUREfi Wealth’s Boston Scientific BSX Stock Holding History

PUREfi Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,696	Closed	-$263K	–	168
2025 Q3	$263K	Buy	+2,696	New	+$279K	0.2%	133

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PUREfi Wealth's BSX Position: Q4 2025 in Review

PUREfi Wealth sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,696 shares — an estimated $263K sold.

PUREfi Wealth first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $263K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

PUREfi Wealth reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
PUREfi Wealth sold 2,696 Boston Scientific shares in Q4 2025, an estimated $263K.
PUREfi Wealth first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
PUREfi Wealth's Boston Scientific position peaked at $263K in Q3 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on PUREfi Wealth's 13F filing for Q4 2025, filed 12 Jan 2026.